Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Novadip Biosciences

Request full access

Regenerative stem cell therapies for critical bone defects

Mont-Saint-Guibert, BelgiumFounded 2013Biotech & Life Sciences

About Novadip Biosciences

Novadip Biosciences is a Belgian late-stage clinical regenerative medicine company spun out of UCLouvain and St. Luc University Hospital in 2013 by Dr Denis Dufrane. Its 3M³ platform uses adipose-derived stem cells in a scaffold-free extracellular matrix to treat large bone defects; lead candidates include autologous NVD-003 for congenital pseudarthrosis of the tibia (pivotal Phase 3) and allogeneic NVD-X3 for trauma and spinal fusion. In September 2026 Novadip closed a €10.4 million (~$12 million) convertible financing led by New Science Ventures with Fund+, Wallonie Entreprendre, VIVES, ORSA Tech, Sambrinvest, Noshaq and Invest.BW, following a €9.6 million convertible loan the prior year (~€20 million convertible since June 2025). Hitting the target unlocks a tranche of an €18 million EIB venture-debt facility; the company cites about €137 million cumulative equity and non-dilutive funding. Sources: EU-Startups 21 Sep 2026; company.

Source: Dealroom company data

At a glance

Status
Operational
Employees
58
Open positions
3
Dealroom signal
80.2/100
Industry
Health
Sub-industry
BioTechnology, Medical Devices
Sector
Biotechnology, Stem Cells, Regenerative Medicine, Spinout, DT and LS, science-based
Technology
Deep Tech
Business model
Manufacturing
Client focus
B2B

Funding history

6 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
DEBTDebt Dec 2023 $20M — European Investment Bank ↗
GRANTOther financing Nov 2022 $18M — Public Service of Wallonia ↗
Showing the latest 2 of 6 recorded eventsBook a demo for the full funding history →

Growth signals

Novadip Biosciences website traffic

Latest recorded traffic for Novadip Biosciences is 7.6K monthly website visits, up 1753.7% over the last three months. Novadip Biosciences's team grew 0% over the past year.

Latest monthly visits7.6K 3-month web change+1753.7% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Novadip Biosciences in the Mont-Saint-Guibert ecosystem

Live from Dealroom

The Novadip Biosciences office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

15 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • Public Service of Wallonia

Series A11 investors entered at this stage

  • New Science Ventures
  • Integrale Advisors
  • Invest.BW
  • FundPlus
  • CR-CP Life Science Fund
  • Vives Partners
  • Investsud
  • Olivier van der Rest
  • Wallonie Entreprendre
  • WE Venture
  • Pierre Drion

Series B and later1 investor entered at this stage

  • European Investment Bank

Other known investors2 additional known investors

  • Cliniques Universitaires Saint-Luc Asbl
  • UCLouvain
Team profiled 9 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
4 countries with
team presence
🇧🇪 Belgium92.3%
🇺🇸 United States3.9%
🇩🇪 Germany1.9%
🇬🇧 United Kingdom1.9%
4 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Novadip Biosciences on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Novadip Biosciences’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.